KARDIGAN INC
KARDNASDAQTrading Snapshot
- Day Range
- $21.79 – $22.46
- 52-Week Range
- $16.25 – $27.00
- Volume
- $2.24B
- Avg Volume
- $1.57B
- Shares Outstanding
- 89.3M
- Next Earnings
- Sep 16, 2026
Fundamentals Snapshot
- Annual Revenue
- $193M
- Last Q Revenue
- $45M
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own KARD
- ✓High-growth profile — revenue up +7.8% YoY with expanding US Equity exposure.
- ✓Healthy economics — 68% gross margin and 8% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About KARDIGAN INC
Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exist. It combines clinical-stage drug programs with artificial intelligence, real-world patient data, and analytics through its “Cardiac Intelligence” platform to accelerate research and improve treatment outcomes. The company was founded by Tassos E. Gianakakos, Jay Edelberg, Bob McDowell, Leslie Leinwand, and Elizabeth McNally in August 2023 and is headquartered in Princeton, NJ.
Otter Score Breakdown
ⓘAnalyst Ratings
ⓘLatest News & Updates
Kardigan Q2 EPS $(4.61) Misses $(0.71) Estimate
Kardigan (NASDAQ:KARD) reported quarterly losses of $(4.61) per share which missed the analyst consensus estimate of $(0.71) by 549.3 percent. This is a 0.65 percent increase over losses of $(4.64) per share from the
2 ‘Strong Buy’ IPO Stocks JPMorgan Thinks Are Worth Watching
The IPO market has made an impressive comeback this year. Momentum began building in the first quarter and accelerated in the second, with traditional IPOs raising $114.1 billion through June 30, 2026 – roughly seven times the amount raised during the first half of 2025. SpaceX, the largest IPO in Wall Street history, understandably dominated the headlines and made Elon Musk the world’s first trillionaire, but the strength of the market extended well beyond a single blockbuster listing.Claim 55%
TD Cowen Initiates Coverage On Kardigan with Buy Rating, Announces Price Target of $46
TD Cowen analyst Ritu Baral initiates coverage on Kardigan (NASDAQ:KARD) with a Buy rating and announces Price Target of $46.
Leerink Partners Initiates Coverage On Kardigan with Outperform Rating, Announces Price Target of $37
Leerink Partners analyst Roanna Ruiz initiates coverage on Kardigan (NASDAQ:KARD) with a Outperform rating and announces Price Target of $37.
This Fastenal Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Wall Street analysts changed outlook on top stocks. To see all changes, visit the analyst ratings page. FAST stock has a Buy rating with $55 PT.
JP Morgan Initiates Coverage On Kardigan with Overweight Rating, Announces Price Target of $51
JP Morgan analyst Anupam Rama initiates coverage on Kardigan (NASDAQ:KARD) with a Overweight rating and announces Price Target of $51.